FlawCheck Citator
Check how courts have cited this case. Use our free citator for the most current treatment.
No. 10664663
United States Court of Appeals for the Ninth Circuit

Wehner v. Genentech, Inc.

No. 10664663 · Decided September 2, 2025
No. 10664663 · Ninth Circuit · 2025 · FlawFinder last updated this page Apr. 2, 2026
Case Details
Court
United States Court of Appeals for the Ninth Circuit
Decided
September 2, 2025
Citation
No. 10664663
Disposition
See opinion text.
Full Opinion
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS SEP 2 2025 MOLLY C. DWYER, CLERK U.S. COURT OF APPEALS FOR THE NINTH CIRCUIT MATTHEW WEHNER, No. 24-2630 D.C. No. Plaintiff - Appellant, 3:20-cv-06894-RS v. MEMORANDUM* GENENTECH, INC.; UNITED STATES ROCHE DC FIDUCIARY COMMITTEE, Defendants - Appellees. Appeal from the United States District Court for the Northern District of California Richard Seeborg, Chief District Judge, Presiding Argued and Submitted August 26, 2025 San Francisco, California Before: HURWITZ, KOH, and JOHNSTONE, Circuit Judges. Matthew Wehner appeals the district court’s dismissal of his claims under the Employee Retirement Income Security Act of 1974 (“ERISA”), 29 U.S.C. § 1001, et seq. We have jurisdiction under 28 U.S.C. § 1291, and we affirm. 1. The district court correctly dismissed Wehner’s claim that defendants, the * This disposition is not appropriate for publication and is not precedent except as provided by Ninth Circuit Rule 36-3. fiduciaries for Genentech’s retirement plan, violated their duty of prudence under ERISA by retaining certain investments (“the Roche TDFs”) in Genentech’s retirement portfolio. ERISA requires plan trustees to act with the “care, skill, prudence, and diligence under the circumstances then prevailing that a prudent man acting in a like capacity and familiar with such matters would use in the conduct of an enterprise of a like character and with like aims.” 29 U.S.C. § 1104(a)(1)(B). “ERISA requires prudence, not prescience.” Anderson v. Intel Corp. Inv. Pol’y Comm., 137 F.4th 1015, 1021 (9th Cir. 2025) (citation modified). “Because we evaluate prudence prospectively, based on the methods the fiduciaries employed, rather than retrospectively, based on the results they achieved, it is not enough for a plaintiff simply to allege that the fiduciaries could have obtained better results . . . by choosing different investments.” Id. at 1021. Rather, “a plaintiff must provide ‘some further factual enhancement’ to take the claim across ‘the line between possibility and plausibility.’” Id. (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 557 (2007)). Wehner’s operative complaint lacked sufficient factual content to plausibly take his claim that defendants violated their duty of prudence under ERISA across the line. As we recently explained, when an ERISA plaintiff attempts to plead imprudence “by relying on a theory that a prudent fiduciary in like circumstances 2 would have selected a different fund based on the cost or performance of the selected fund, that plaintiff must provide a sound basis for comparison.” Id. at 1022. With regard to Wehner’s proposed comparators, the operative complaint lacks the factual content that Anderson requires to give rise to a plausible inference of breach of the duty of prudence. See id. (explaining that merely “labeling funds as ‘comparable’ or ‘a peer’ is insufficient to establish that those funds are meaningful benchmarks against which to compare the performance of the [Roche TDFs]”). Likewise, Wehner’s allegations regarding defendants’ investment manager fail to “nudge[]” his duty of prudence claim “across the line from conceivable to plausible.” Twombly, 550 U.S. at 570; see also Hughes v. Nw. Univ., 595 U.S. 170, 177 (2022) (explaining that “the circumstances facing an ERISA fiduciary will implicate difficult tradeoffs, and courts must give due regard to the range of reasonable judgments a fiduciary may make based on her experience and expertise”). 2. We also affirm the district court’s dismissal of Wehner’s claim that defendants failed to monitor co-fiduciaries under 29 U.S.C. § 1105(a) because that claim is derivative of Wehner’s duty of prudence claim.1 AFFIRMED. 1 Because Wehner does not assert on appeal that he should have been granted leave to amend the operative complaint, we do not address the issue. 3
Plain English Summary
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS SEP 2 2025 MOLLY C.
Key Points
Frequently Asked Questions
NOT FOR PUBLICATION FILED UNITED STATES COURT OF APPEALS SEP 2 2025 MOLLY C.
FlawCheck shows no negative treatment for Wehner v. Genentech, Inc. in the current circuit citation data.
This case was decided on September 2, 2025.
Use the citation No. 10664663 and verify it against the official reporter before filing.
Why Attorneys Choose FlawFinder

Why Attorneys Choose FlawFinder

Side-by-side with Westlaw and LexisNexis

Feature FlawFinder Westlaw LexisNexis
Monthly price$19 – $99$133 – $646$153 – $399
ContractNone1–3 year min1–6 year min
Hidden fees$0, alwaysUp to $469/search$25/mo + per-doc
FlawCheck citatorIncludedKeyCite ($$$)Shepard's ($$$)
Plain-English summaryIncludedNoNo
CancelOne clickTermination feesAccount friction
Related Cases

Full legal research for $19/month

All 50 states · Federal regulations · Case law · Police SOPs · AI analysis included · No contract

Continue Researching →